Literature DB >> 2802258

Hypercoagulability in arterial disease.

C R Spillert1, V J Milazzo, W D Suval, E J Lazaro.   

Abstract

Isolated human monocytes generate tissue factor when stimulated with endotoxin. Tissue factor generation provides a marker for activation of the monocyte and of the clotting system. Determination of the recalcification time of blood after incubation with endotoxin detects minute changes in coagulability. This clotting assay was utilized to assess the presence of a hypercoagulable state in patients with peripheral arterial occlusive disease when compared with healthy volunteers. Citrated blood was incubated with endotoxin for two hours, CaCl2 was added, and the recalcification time determined. Hypercoagulability was indicated by shortened recalcification time. The recalcification time +/- standard deviation for saline (control) and endotoxin-activated samples from 19 healthy volunteers was 6.55 +/- 0.8 and 5.69 +/- 0.7 minutes, respectively, whereas it was 4.93 +/- 1.2 and 4.55 +/- 0.9 minutes for 31 patients with peripheral arterial occlusive disease (p less than .001 for each). This hypercoagulable state can accentuate the arterial occlusive process in patients with peripheral vascular disease and may prove to be of diagnostic, therapeutic, and prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802258     DOI: 10.1177/000331978904001005

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

1.  Effect of methylprednisolone on coagulation.

Authors:  H B Pandit; C R Spillert
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

2.  Contribution of the monocyte to thrombotic potential.

Authors:  C R Spillert; E J Lazaro
Journal:  Agents Actions       Date:  1991-09

3.  Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

4.  Altered coagulability: an aid to selective breast biopsy.

Authors:  C R Spillert; M R Passannante; J E Salzer-Pagan; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

5.  Role of platelet age in assessment of coagulation.

Authors:  C R Spillert; C S Lee; E E Federici; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1995-12       Impact factor: 1.798

6.  In vitro effect of hirudin on recalcification time.

Authors:  J Hirsh; C R Spillert; E P Delle Donne; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

7.  Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.

Authors:  C R Spillert; S Sun; M A Miller; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

8.  Modified recalcification time: a global coagulation screening test.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.